These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26211622)

  • 1. Comparison of automated brain segmentation using a brain phantom and patients with early Alzheimer's dementia or mild cognitive impairment.
    Fellhauer I; Zöllner FG; Schröder J; Degen C; Kong L; Essig M; Thomann PA; Schad LR
    Psychiatry Res; 2015 Sep; 233(3):299-305. PubMed ID: 26211622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths.
    Heinen R; Bouvy WH; Mendrik AM; Viergever MA; Biessels GJ; de Bresser J
    PLoS One; 2016; 11(10):e0165719. PubMed ID: 27798694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis.
    Guo C; Ferreira D; Fink K; Westman E; Granberg T
    Eur Radiol; 2019 Mar; 29(3):1355-1364. PubMed ID: 30242503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
    Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
    Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
    PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?
    Rajagopalan V; Pioro EP
    BMC Neurol; 2015 Mar; 15():32. PubMed ID: 25879588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter assessment of reliability of cranial MRI.
    Ewers M; Teipel SJ; Dietrich O; Schönberg SO; Jessen F; Heun R; Scheltens P; van de Pol L; Freymann NR; Moeller HJ; Hampel H
    Neurobiol Aging; 2006 Aug; 27(8):1051-9. PubMed ID: 16169126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
    Wood PL; Barnette BL; Kaye JA; Quinn JF; Woltjer RL
    Acta Neuropsychiatr; 2015 Oct; 27(5):270-8. PubMed ID: 25858158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P; Carter SF; Rinne JO; Gelosa G; Herholz K; Nordberg A; Brooks DJ; Hinz R
    Neuroimage; 2013 Apr; 70():423-33. PubMed ID: 23261639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.
    Guo Y; Zhang Z; Zhou B; Wang P; Yao H; Yuan M; An N; Dai H; Wang L; Zhang X; Liu Y
    Neurosci Bull; 2014 Jun; 30(3):477-89. PubMed ID: 24760581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
    Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
    Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment.
    Sohn BK; Yi D; Seo EH; Choe YM; Kim JW; Kim SG; Choi HJ; Byun MS; Jhoo JH; Woo JI; Lee DY
    J Korean Med Sci; 2015 Jun; 30(6):779-87. PubMed ID: 26028932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining anatomical, diffusion, and resting state functional magnetic resonance imaging for individual classification of mild and moderate Alzheimer's disease.
    Schouten TM; Koini M; de Vos F; Seiler S; van der Grond J; Lechner A; Hafkemeijer A; Möller C; Schmidt R; de Rooij M; Rombouts SARB
    Neuroimage Clin; 2016; 11():46-51. PubMed ID: 26909327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.